| Fluconazole 200 mg hard capsule PA2315/090/003 |
Fluconazole |
Accord Healthcare Ireland Ltd. |
Marketed |
| Fluconazole 50 mg hard capsules PA2315/090/001 |
Fluconazole |
Accord Healthcare Ireland Ltd. |
Marketed |
| Fludarabine Phosphate 25 mg/ml Concentrate for Solution for Injection or Infusion PA2315/035/001 |
Fludarabine phosphate |
Accord Healthcare Ireland Ltd. |
Marketed |
| Fludrocortisone Acetate Renata 0.1 mg tablets PA22865/007/001 |
Fludrocortisone acetate |
Renata Pharmaceuticals (Ireland) Limited |
Not marketed |
| Fluorouracil 25 mg/ml Solution for Injection or Infusion PA0822/223/001 |
Fluorouracil sodium |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Fluorouracil 50 mg/ml Solution for Injection or Infusion PA2315/091/001 |
Fluorouracil |
Accord Healthcare Ireland Ltd. |
Marketed |
| Fluoxetine 20mg Hard Capsules PA22749/002/001 |
Fluoxetine |
Brillpharma (Ireland) Limited |
Not marketed |
| Fluoxetine 60 mg Hard Capsules PA22749/002/002 |
Fluoxetine |
Brillpharma (Ireland) Limited |
Not marketed |
| Fluticasone propionate 50 micrograms/actuation, nasal spray, suspension PA0678/118/001 |
Fluticasone propionate (micronised) |
Haleon Ireland Limited |
Not marketed |
| Folinic Acid (as Calcium Folinate) 15mg Tablets PA0822/198/001 |
Calcium folinate hydrate |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Fortacin 150 mg/ml + 50 mg/ml cutaneous spray, solution EU/1/13/381/001 |
Lidocaine, Prilocaine |
Recordati Ireland Limited |
— |
| FOSAMAX Once Weekly 70 mg tablets PA23198/003/001 |
Alendronic acid |
Organon Pharma (Ireland) Limited |
Marketed |
| Foznol 1000 mg Chewable Tablets PA23211/002/004 |
Lanthanum |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Foznol 1000 mg Oral Powder PA23211/002/006 |
Lanthanum carbonate hydrate |
Takeda Pharmaceuticals International AG Ireland Branch |
Not marketed |
| Foznol 250 mg Chewable Tablets PA23211/002/001 |
Lanthanum carbonate hydrate |
Takeda Pharmaceuticals International AG Ireland Branch |
Not marketed |
| Foznol 500 mg Chewable Tablets PA23211/002/002 |
Lanthanum |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Foznol 750 mg Chewable Tablets PA23211/002/003 |
Lanthanum |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Foznol 750 mg Oral Powder PA23211/002/005 |
Lanthanum carbonate hydrate |
Takeda Pharmaceuticals International AG Ireland Branch |
Not marketed |
| Frumil 40mg/5mg Tablets PA0540/101/002 |
Furosemide, AMILORIDE HYDROCHLORIDE |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Fulphila 6 mg solution for injection in pre-filled syringe EU/1/18/1329/001-002 |
Pegfilgrastim |
Biosimilar Collaborations Ireland Limited |
— |
| Fulvestrant 250 mg Solution for injection in pre-filled syringe PA2315/046/001 |
Fulvestrant |
Accord Healthcare Ireland Ltd. |
Marketed |
| Furosemide 10 mg/ml Solution for Injection or Infusion PA2315/163/001 |
Furosemide |
Accord Healthcare Ireland Ltd. |
Marketed |
| Furosemide 20mg in 2ml Solution for Injection PA0073/059/004 |
Furosemide |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Furosemide 250mg in 25ml Solution for Injection/Infusion PA0073/059/006 |
Furosemide |
Mercury Pharmaceuticals (Ireland) Ltd |
Not marketed |
| Furosemide 50mg in 5ml Solution for Injection PA0073/059/005 |
Furosemide |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Furosemide Bristol 20 mg Tablets PA22749/001/001 |
Furosemide |
Brillpharma (Ireland) Limited |
Marketed |
| Furosemide Bristol 40 mg Tablets PA22749/001/002 |
Furosemide |
Brillpharma (Ireland) Limited |
Marketed |
| Fybogel Citrus 3.5 g Granules PA0979/009/001 |
Ispaghula husks |
Reckitt Benckiser Ireland Limited |
Not marketed |
| Fybogel Mebeverine Granules for Oral Suspension Ispaghula Husk 3.5g Mebeverine Hydrochloride 135mg PA0979/010/001 |
Mebeverine hydrochloride, Ispaghula husks |
Reckitt Benckiser Ireland Limited |
Not marketed |
| Fybogel Orange 3.5 g granules PA0979/009/002 |
Ispaghula husks |
Reckitt Benckiser Ireland Ltd, |
Marketed |
| Gabapentin 100 mg hard capsules PA2315/164/003 |
Gabapentin |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Gabapentin 300 mg hard capsules PA2315/164/004 |
Gabapentin |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Gabapentin 400 mg hard capsules PA2315/164/005 |
Gabapentin |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Gabapentin 600 mg film-coated tablets PA2315/164/001 |
Gabapentin |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Gabapentin 800 mg film-coated tablets PA2315/164/002 |
Gabapentin |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Gabapentin Rosemont 50 mg/ml Oral Solution PA23081/010/001 |
Gabapentin |
Taw Pharma (Ireland) Limited |
Marketed |
| Gaviscon Advance Chewable Tablets Sodium alginate 500 mg, Potassium hydrogen carbonate 100 mg. PA0979/011/008 |
Sodium alginate, Potassium hydrogen carbonate |
Reckitt Benckiser Ireland Ltd |
Marketed |
| Gaviscon Advance Oral Suspension Sodium alginate 500 mg, Potassium hydrogen carbonate 100 mg. PA0979/011/001 |
Sodium alginate, Potassium hydrogen carbonate |
Reckitt Benckiser Ireland Ltd |
Marketed |
| Gaviscon Advance Peppermint Oral Suspension Sachets Sodium Alginate 500mg, Potassium hydrogen carbonate 100 mg Oral suspension. PA0979/011/006 |
Sodium alginate, Potassium hydrogen carbonate |
Reckitt Benckiser Ireland Ltd |
Not marketed |
| Gaviscon Advance Peppermint Oral Suspension Sodium alginate 500 mg, Potassium hydrogen carbonate 100 mg. PA0979/011/007 |
Sodium alginate, Potassium hydrogen carbonate |
Reckitt Benckiser Ireland Ltd |
Not marketed |
| Gaviscon Extra Chewable TabletsSodium alginate 250mgSodium bicarbonate 106.5mgCalcium carbonate 187.5mg PA0979/015/012 |
Sodium alginate, Sodium bicarbonate, Calcium carbonate |
Reckitt Benckiser Ireland Ltd |
Marketed |
| Gaviscon Extra Liquid Sachets Peppermint Flavour Oral SuspensionSodium Alginate 500 mg/10 ml Sodium Bicarbonate 213 mg/10 ml Calcium Carbonate 325 mg/10 ml PA0979/015/013 |
Sodium alginate, Sodium bicarbonate, Calcium carbonate |
Reckitt Benckiser Ireland Ltd |
Not marketed |
| Gaviscon Extra Mixed Berries Flavour Chewable Tablets Sodium alginate 250 mg Sodium hydrogen carbonate 106.5 mg Calcium carbonate 187.5 mg PA0979/082/001 |
Sodium alginate, Sodium hydrogen carbonate, Calcium carbonate |
Reckitt Benckiser Ireland Ltd, |
Not marketed |
| Gaviscon Extra Mixed Berries Flavour Oral Suspension in Sachet Sodium alginate 500 mg/10ml Sodium hydrogen carbonate 213 mg/ 10ml Calcium carbonate 325 mg/ 10ml PA0979/083/001 |
Sodium alginate, Sodium hydrogen carbonate, Calcium carbonate |
Reckitt Benckiser Ireland Limited |
— |
| Gaviscon Extra Mixed Berries Oral Suspension Sodium alginate 500 mg/ 10 ml sodium hydrogen carbonate 213 mg/ 10 ml Calcium carbonate 325 mg/ 10 ml PA0979/084/001 |
Sodium alginate, Sodium hydrogen carbonate, Calcium carbonate |
Reckitt Benckiser Ireland Limited |
Not marketed |
| Gaviscon Extra Oral Suspension Sodium alginate 500 mg Sodium bicarbonate 213 mg Calcium carbonate 325 mg PA0979/015/011 |
Sodium alginate, Sodium bicarbonate, Calcium carbonate |
Reckitt Benckiser Ireland Ltd |
Marketed |
| Gaviscon Infant, Powder for Oral Suspension PA0979/012/001 |
Sodium alginate, Magnesium alginate |
Reckitt Benckiser Ireland Ltd |
Marketed |
| Gaviscon Liquid Peppermint Flavour, Oral Suspension Sodium alginate 500 mg Sodium bicarbonate 267 mg Calcium carbonate 160 mg PA0979/015/002 |
Sodium alginate, Calcium carbonate, Sodium bicarbonate |
Reckitt Benckiser Ireland Ltd |
Marketed |
| Gaviscon Liquid Sachets Oral Suspension Sodium alginate 500mg, Sodium bicarbonate 267mg, Calcium carbonate 160mg PA0979/015/010 |
Sodium alginate, Sodium bicarbonate, Calcium carbonate |
Reckitt Benckiser Ireland Ltd |
Not marketed |
| Gaviscon Liquid-Aniseed Flavour, Oral Suspension Each 10 ml contains: Sodium alginate 500 mg Sodium bicarbonate 267 mg Calcium carbonate 160 mg PA0979/015/003 |
Sodium bicarbonate, Calcium carbonate, Sodium alginate |
Reckitt Benckiser Ireland Ltd |
Marketed |